H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1

Cancer Letters

Volumn 305, Issue 1, 2011, Pages 58-68

  Ibañez, Irene L ^a,b   Policastro, Lucía L ^a,b   Tropper, Ivanna ^c   Bracalente, Candelaria ^a   Palmieri, Mónica A ^d   Rojas, Paola A ^b   Molinari, Beatriz L ^a,b   Durán, Hebe ^a,b,c  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cancer cells; Cell cycle; Cyclin D1; Hydrogen peroxide; P27kip1; Proliferation

Indexed keywords

CATALASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LEVEL; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SQUAMOUS CELL CARCINOMA; ACTIVE TRANSPORT; ANIMAL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NUDE MOUSE; SENSITIVE TO CARCINOGENESIS MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BLOTTING, WESTERN; CATALASE; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FREE RADICAL SCAVENGERS; G1 PHASE; HYDROGEN PEROXIDE; MICE; MICE, INBRED SENCAR; MICE, NUDE; REACTIVE OXYGEN SPECIES; S PHASE;

EID: 79953195101     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.02.026     Document Type: Article

References (51)

1. Davies K.J. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000, 50:279-289.
2. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., Parthasarathy S., Petros J.A., Lambeth J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA 2001, 98:5550-5555.
3. Policastro L., Molinari B., Larcher F., Blanco P., Podhajcer O.L., Costa C.S., Rojas P., Durán H. Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol. Carcinog. 2004, 39:103-113.
4. Laurent A., Nicco C., Chéreau C., Goulvestre C., Alexandre J., Alves A., Lévy E., Goldwasser F., Panis Y., Soubrane O., Weill B., Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005, 65:948-956.
5. 2 induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radical Biol. Med. 2001, 30:1008-1018.
6. Carreras M.C., Converso D.P., Lorenti A.S., Barbich M., Levisman D.M., Jaitovich A., Antico Arciuch V.G., Galli S., Poderoso J.J. Mitochondrial nitric oxide synthase drives redox signals for proliferation and quiescence in rat liver development. Hepatology 2004, 40:157-166.
7. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
8. Halliwel B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007, 401:1-11.
9. Irani K., Xia Y., Zweier J.L., Sollot S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997, 275:1649-1652.
10. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 2006, 71:226-235.
11. Nelson K.K., Ranganathan A.C., Mansouri J., Rodriguez A.M., Providence K.M., Rutter J.L., Pumiglia K., Bennett J.A., Melendez J.A. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. 2003, 9:424-432.
12. McCord J.M. Superoxide radical: controversies, contradictions, and paradoxes. Proc. Soc. Exp. Biol. Med. 1995, 209:112-117.
13. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.
14. Policastro L.L., Ibañez I.L., Durán H.A., Soria G., Gottifredi V., Podhajcer O.L. Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter. Mol. Ther. 2009, 17:1355-1364.
15. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995, 358:1-3.
16. Kondo S., Toyokuni S., Iwasa Y., Tanaka T., Onodera H., Hiai H., Imamura M. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radical Biol. Med. 1999, 27:401-410.
17. Hempel N., Ye H., Abessi B., Mian B., Melendez J.A. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radical Biol. Med. 2009, 46:42-50.
18. Guyton K.Z., Kensler T.W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 1993, 49:523-544.
19. Cerutti P.A. Prooxidant states and tumor promotion. Science 1985, 227:375-381.
20. Hyoudou K., Nishikawa M., Ikemura M., Kobayashi Y., Mendelsohn A., Miyazaki N., Tabata Y., Yamashita F., Hashida M. Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase. J. Controlled Release 2009, 137:110-115.
21. Onumah O.E., Jules G.E., Zhao Y., Zhou L., Yang H., Guo Z. Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells. Free Radical Biol. Med. 2009, 46:1658-1667.
22. Stone J.R., Yang S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 2006, 8:243-270.
23. Cakir Y., Ballinger S.W. Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK. Antioxid. Redox Signal. 2005, 7:726-740.
24. Benhar M., Engelberg D., Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 2002, 3:420-425.
25. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672.
26. Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
27. KIP1 metabolism: a fascinating labyrinth. Cell Cycle 2007, 6:1053-1061.
28. Menon S.G., Sarsour E.H., Spitz D.R., Higashikubo R., Sturm M., Zhang H., Goswami P.C. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res. 2003, 63:2109-2117.
29. Sarsour E.H., Kumar M.G., Chaudhuri L., Kalenand A.L., Goswami P.C. Redox control of the cell cycle in health and disease. Antioxid. Redox Signal. 2009, 11:2985-3011.
30. Burch P.M., Heintz N.H. Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid. Redox Signal. 2005, 7:741-751.
31. Felty Q., Singh K.P., Roy D. Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 2005, 24:4883-4893.
32. Conti C.J., Fries J.W., Viaje A., Miller D.R., Morris R., Slaga T.J. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res. 1988, 48:435-439.
33. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1997, 69:581-593.
34. Deng X., Gao F., May W.S. Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 2003, 102:3179-3185.
35. Martín V., Herrera F., García-Santos G., Antolín I., Rodriguez-Blanco J., Rodriguez C. Signaling pathways involved in antioxidant control of glioma cell proliferation. Free Radical Biol. Med. 2007, 42:1715-1722.
36. 2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J. Biol. Chem. 2001, 276:9558-9564.
37. Weber J.D., Raben D.M., Phillips P.J., Baldassare J.J. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 1997, 326:61-68.
38. Menon S.G., Sarsour E.H., Kalen A.L., Venkataraman S., Hitchler M.J., Domann F.E., Oberley L.W., Goswami P.C. Superoxide signaling mediates N-acetyl-l-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res. 2007, 67:6392-6399.
39. 2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J. Biol. Chem. 2002, 277:13761-13770.
40. Tashiro E., Tsuchiya A., Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007, 98:629-635.
41. Robles A.I., Conti C.J. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 1995, 16:781-786.
42. Rodríguez-Puebla M.L., Robles A.I., Conti C.J. Ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development. Mol. Carcinog. 1999, 24:1-6.
43. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., Pestell R.G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 1995, 270:23589-23597.
44. Sa G., Stacey D.W. Stacey P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase. Exp. Cell. Res. 2004, 300:427-439.
45. Rivard N., Boucher M.J., Asselin C., L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 1999, 277:C652-C664.
46. Larrea M.D., Wander S.A., Slingerland J.M. P27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 2009, 8:3455-3461.
47. KIP1 are directly regulated by oncogenic tyrosine kinases. Cell 2007, 128:269-280.
48. Chu I., Sun J., Arnaout A., Kahn H., Hanna W., Narod S., Sun P., Tan C.K., Hengstand L., Slingerland J. P27 phosphorylation by src regulates inhibition of cyclin E-Cdk2. Cell 2007, 128:281-294.
49. KIP1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 2002, 8:1136-1144.
50. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssenand E., Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 2002, 8:1153-1160.
51. KIP1 controls its cyclin D-cdk4 inhibitory activity. Mol. Cell. Biol. 2008, 28:498-510.